Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Alan S. Gamis, Franklin O. Smith, Yaddanapudi Ravindranath et al.|Blood|2011Cited by 230
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology GroupRichard Aplenc, Stella M. Davies, Todd A. Alonzo et al.|Blood|2006Cited by 131
Clinical Impact of Additional Cytogenetic Aberrations, <i>cKIT</i> and <i>RAS</i> Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study GroupKim Klein, Brenda Gibson, Gertjan J.L. Kaspers et al.|Journal of Clinical Oncology|2015Cited by 92
Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemiaAlan S. Gamis, Soheil Meshinchi, Todd A. Alonzo et al.|Pediatric Blood & Cancer|2012Cited by 83
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patientsJason Canner, John Horan, Todd A. Alonzo et al.|Cancer|2013Cited by 75